| Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome.Arterioscler Thromb Vasc Biol | Random groups | 2012 |
| Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.J Clin Endocrinol Metab | Random groups | 2011 |
| TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes.Biochim Biophys Acta | No random groups | 2012 |
| Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.J Biol Chem | No random groups | 2007 |
| Reversible Gynecomastia and Hypogonadism Due to Usage of Commercial Performance-Enhancing Supplement Use.JCEM Case Rep | Case reports | 2024 |
| Multiple prohibited ingredients detected in nutritional supplements in a case of adverse analytical finding (AAF).Drug Test Anal | Case reports | 2022 |
| Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD).Pharmacol Res | Review of studies | 2023 |
| PPARδ and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson's disease.Mol Aspects Med | Review of studies | 2021 |
| Endogenous hydrogen sulfide improves vascular remodeling through PPARδ/SOCS3 signaling.J Adv Res | Review of studies | 2021 |
| Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls.Biochem Pharmacol | Review of studies | 2018 |
| Exercise in a Pill: The Latest on Exercise-Mimetics.Brain Plast | Review of studies | 2017 |
| Recent Updates on Peroxisome Proliferator-Activated Receptor δ Agonists for the Treatment of Metabolic Syndrome.Med Chem | Review of studies | 2016 |
| Metabolic modulators of the exercise response: doping control analysis of an agonist of the peroxisome proliferator-activated receptor δ (GW501516) and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR).J Physiol Pharmacol | Review of studies | 2014 |
| New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.Expert Opin Pharmacother | Review of studies | 2014 |
| Harnessing the benefits of PPARβ/δ agonists.Life Sci | Review of studies | 2013 |
| Dual acting and pan-PPAR activators as potential anti-diabetic therapies.Handb Exp Pharmacol | Review of studies | 2011 |
| PPARdelta in humans: genetic and pharmacological evidence for a significant metabolic function.Curr Opin Lipidol | Review of studies | 2009 |
| [Design and synthesis of peroxisome proliferator-activated receptor (PPAR) delta agonists and its implication to the driving force to elicit PPAR delta selectivity].Yakugaku Zasshi | Review of studies | 2009 |
| Lipids, lipoproteins, and peroxisome proliferator activated receptor-delta.Am J Cardiol | Review of studies | 2007 |
| Evolution of peroxisome proliferator-activated receptor agonists.Ann Pharmacother | Review of studies | 2007 |
| GW-501516 GlaxoSmithKline/Ligand.Curr Opin Investig Drugs | Review of studies | 2006 |
| Cardiovascular disease and PPARdelta: targeting the risk factors.Curr Opin Investig Drugs | Review of studies | 2005 |
| WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth.Cell Cycle | Review of studies | 2004 |
| PPARβ/δ contributes to the antidiabetic effect and the increase in GDF15 caused by metformin.Acta Pharmacol Sin | In animals | 2026 |
| Peroxisome Proliferator-Activated Receptor Delta Regulates Myogenic Differentiation via Lipid Droplet-Associated Metabolic Remodeling and p38 MAPK Signaling.Anim Sci J | In animals | 2026 |
| GLP-1 receptor agonist protects glucose-stimulated insulin secretion in pancreatic β-cells against lipotoxicity via PPARδ/UCP2 pathway.Cell Mol Life Sci | In animals | 2025 |
| Fatty acid metabolism suppresses neonatal cardiomyocyte proliferation by increasing PDK4 and HMGCS2 expression through PPARδ.PLoS One | In animals | 2025 |
| PPARβ/δ upregulates the insulin receptor β subunit in skeletal muscle by reducing lysosomal activity and EphB4 levels.Cell Commun Signal | In animals | 2024 |
| Selective PPARδ Agonist GW501516 Protects Against LPS-Induced Macrophage Inflammation and Acute Liver Failure in Mice via Suppressing Inflammatory Mediators.Molecules | In animals | 2024 |
| Estradiol contributes to sex differences in resilience to sepsis-induced metabolic dysregulation and dysfunction in the heart via GPER-1-mediated PPARδ/NLRP3 signaling.Metabolism | In animals | 2024 |
| Inhibitory Effect of PPARδ Agonist GW501516 on Proliferation of Hypoxia-induced Pulmonary Arterial Smooth Muscle Cells by Regulating the mTOR Pathway.Curr Med Sci | In animals | 2023 |
| Medium-chain fatty acids modify macrophage expression of metabolic and inflammatory genes in a PPAR β/δ-dependent manner.Sci Rep | In animals | 2023 |
| Regulation of adipogenesis through retinoid X receptor and/or peroxisome proliferator-activated receptor by designed lignans based on natural products in 3T3-L1 cells.J Nat Med | In animals | 2023 |
| Anti-inflammatory effects and improved metabolic derangements in ob/ob mice by a newly synthesized prenylated benzopyran with pan-PPAR activity.Pharmacol Res | In animals | 2023 |
| Molecular and Physiological Effects of Browning Agents on White Adipocytes from Bone Marrow Mesenchymal Stromal Cells.Int J Mol Sci | In animals | 2022 |
| [Effects of GW501516 on the proliferation of pulmonary artery smooth muscle cells induced by hypoxia and its mechanisms].Zhongguo Ying Yong Sheng Li Xue Za Zhi | In animals | 2022 |
| Peroxisome proliferator-activated receptor δ rescues xCT-deficient cells from ferroptosis by targeting peroxisomes.Biomed Pharmacother | In animals | 2021 |
| Comprehensive characterization of the peroxisome proliferator activated receptor-δ agonist GW501516 for horse doping control analysis.Drug Test Anal | In animals | 2021 |
| Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes.Int J Mol Sci | In animals | 2020 |
| Mitochondrial dysfunction and consequences in calpain-3-deficient muscle.Skelet Muscle | In animals | 2020 |
| Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆.J Hepatol | In animals | 2020 |
| Regulation of Lin28a-miRNA let-7b-5p pathway in skeletal muscle cells by peroxisome proliferator-activated receptor delta.Am J Physiol Cell Physiol | In animals | 2020 |
| Peroxisome Proliferator-Activated Receptor Beta/Delta Agonist Suppresses Inflammation and Promotes Neovascularization.Int J Mol Sci | In animals | 2020 |
| The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos.Int J Mol Sci | In animals | 2019 |
| Activated PPARβ/δ Protects Pancreatic β Cells in Type 2 Diabetic Goto-Kakizaki Rats from Lipoapoptosis via GPR40.Lipids | In animals | 2019 |
| Adipose tissue macrophage-derived exosomal miR-29a regulates obesity-associated insulin resistance.Biochem Biophys Res Commun | In animals | 2019 |
| PPARβ/δ agonist GW501516 inhibits TNFα-induced repression of adiponectin and insulin receptor in 3T3-L1 adipocytes.Biochem Biophys Res Commun | In animals | 2019 |
| Discovery of first-in-class thiazole-based dual FFA1/PPARδ agonists as potential anti-diabetic agents.Eur J Med Chem | In animals | 2019 |
| Ligand-activated PPARδ inhibits angiotensin II-stimulated hypertrophy of vascular smooth muscle cells by targeting ROS.PLoS One | In animals | 2019 |
| PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.Behav Brain Res | In animals | 2019 |
| Peroxisome proliferator-activated receptor β/δ does not regulate glucose uptake and lactose synthesis in bovine mammary epithelial cells cultivated in vitro.J Dairy Res | In animals | 2018 |
| Activation of PPARδ attenuates neurotoxicity by inhibiting lipopolysaccharide-triggered glutamate release in BV-2 microglial cells.J Cell Biochem | In animals | 2018 |
| Ligand-Activated Peroxisome Proliferator-Activated Receptor δ Attenuates Vascular Oxidative Stress by Inhibiting Thrombospondin-1 Expression.J Vasc Res | In animals | 2018 |
| PPARδ activation protects H9c2 cardiomyoblasts from LPS‑induced apoptosis through the heme oxygenase‑1‑mediated suppression of NF‑κB activation.Mol Med Rep | In animals | 2017 |
| Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia.Sci Rep | In animals | 2017 |
| Peroxisome proliferator-activated receptor δ improves porcine blastocyst hatching via the regulation of fatty acid oxidation.Theriogenology | In animals | 2017 |
| Protective Role of PPARdelta in Lipoapoptosis of Pancreatic β Cells.Lipids | In animals | 2016 |
| Sirtuin 1 Mediates the Actions of Peroxisome Proliferator-Activated Receptor δ on the Oxidized Low-Density Lipoprotein-Triggered Migration and Proliferation of Vascular Smooth Muscle Cells.Mol Pharmacol | In animals | 2016 |
| PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.Mol Neurobiol | In animals | 2016 |
| Short-term administration of GW501516 improves inflammatory state in white adipose tissue and liver damage in high-fructose-fed mice through modulation of the renin-angiotensin system.Endocrine | In animals | 2015 |
| Protective Effect of Unsaturated Fatty Acids on Palmitic Acid-Induced Toxicity in Skeletal Muscle Cells is not Mediated by PPARδ Activation.Lipids | In animals | 2015 |
| Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model.Int J Mol Med | In animals | 2015 |
| A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice.Sci Rep | In animals | 2015 |
| PPARδ modulates oxLDL-induced apoptosis of vascular smooth muscle cells through a TGF-β/FAK signaling axis.Int J Biochem Cell Biol | In animals | 2015 |
| Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction.Am J Physiol Heart Circ Physiol | In animals | 2015 |
| Peroxisome proliferator-activated receptor δ promotes the progression of posttraumatic osteoarthritis in a mouse model.Arthritis Rheumatol | In animals | 2015 |
| Activation of peroxisome proliferator activator receptor delta in mouse impacts lipid composition and placental development at early stage of gestation.Biol Reprod | In animals | 2014 |
| Schistosoma japonicum soluble egg antigens facilitate hepatic stellate cell apoptosis by downregulating Akt expression and upregulating p53 and DR5 expression.PLoS Negl Trop Dis | In animals | 2014 |
| Effects of the peroxisome proliferator-activated receptor (PPAR)-δ agonist GW501516 on bone and muscle in ovariectomized rats.Endocrinology | In animals | 2014 |
| PPARδ reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice by regulating extracellular matrix homeostasis and inflammatory responses.Int J Cardiol | In animals | 2014 |
| The PPARβ/δ agonist GW501516 attenuates peritonitis in peritoneal fibrosis via inhibition of TAK1-NFκB pathway in rats.Inflammation | In animals | 2014 |
| PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats.Int J Obes (Lond)Retracted | In animals | 2014 |
| Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.Cell Signal | In animals | 2014 |
| Activation of peroxisome proliferator-activated receptor δ inhibits angiotensin II-induced activation of matrix metalloproteinase-2 in vascular smooth muscle cells.J Vasc Res | In animals | 2014 |
| Effects of peroxisome proliferator-activated receptor-β/δ on sepsis induced acute lung injury.Chin Med J (Engl) | In animals | 2014 |
| PPARδ induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation.Cancer Res | In animals | 2013 |
| The effects of PPARδ agonist and zinc on ovariectomized rats' vagina.Female Pelvic Med Reconstr Surg | In animals | 2013 |
| Activation of PPAR-α induces cell cycle arrest and inhibits transforming growth factor-β1 induction of smooth muscle cell phenotype in 10T1/2 mesenchymal cells.Cell Signal | In animals | 2013 |
| [PPARβ/δ Activation prevents hypertriglyceridemia caused by a high fat diet. Involvement of AMPK and PGC-1α-Lipin1-PPARα pathway].Clin Investig Arterioscler | In animals | 2013 |
| Effect of PPARβ/δ agonist on the placentation and embryo-fetal development in rats.Birth Defects Res B Dev Reprod Toxicol | In animals | 2013 |
| PPARδ agonist GW501516 prevents uncoupling of endothelial nitric oxide synthase in cerebral microvessels of hph-1 mice.Brain Res | In animals | 2012 |
| Activation of peroxisome proliferator-activated receptor-δ attenuates glutamate-induced neurotoxicity in HT22 mouse hippocampal cells.J Neurosci Res | In animals | 2012 |
| Reactive oxygen species signaling facilitates FOXO-3a/FBXO-dependent vascular BK channel β1 subunit degradation in diabetic mice.Diabetes | In animals | 2012 |
| PPARβ/δ priming enhances mesenchymal stromal cell anti-apoptotic properties on chondrocytes via ANGPTL4 and improves their therapeutic effects in osteoarthritis.Stem Cells Transl Med | In a lab dish | 2026 |
| Peroxisome proliferator-activated receptor-δ-mediated upregulation of catalase helps to reduce ultraviolet B-induced cellular injury in dermal fibroblasts.J Dermatol Sci | In a lab dish | 2021 |
| PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.Diabetologia | In a lab dish | 2014 |
| PPARδ inhibits UVB-induced secretion of MMP-1 through MKP-7-mediated suppression of JNK signaling.J Invest Dermatol | In a lab dish | 2013 |
| Effects of PPAR-delta agonist and zinc on vaginal smooth muscle cells collagen and tropoelastin production.Int Urogynecol J | In a lab dish | 2012 |
| Role of lipid peroxidation and PPAR-δ in amplifying glucose-stimulated insulin secretion.Diabetes | In a lab dish | 2011 |
| Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.Toxicology | In a lab dish | 2008 |
| PPARdelta activator GW-501516 has no acute effect on glucose transport in skeletal muscle.Am J Physiol Endocrinol Metab | In a lab dish | 2006 |
| Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.Arthritis Rheum | In a lab dish | 2005 |
| Investigation of exercise-mimetic bioactive molecules as modulators of MMP activity and expression in cancer cells.J Enzyme Inhib Med Chem | Other paper | 2026 |
| Ferroptosis Regulates Metabolic Inflammation-Driven Tumorigenesis in Obesity-Related Gastric Cancer.Cell Mol Gastroenterol Hepatol | Other paper | 2026 |
| A magnetic-acoustic dual-fesponsive nanoplatform for targeted PPARδ activation attenuates adolescent idiopathic scoliosis progression.J Nanobiotechnology | Other paper | 2026 |
| SARMs, Metabolic Modulators and Growth Hormone Secretagogues in Suspected Illegal Medicines, Bought as Sport Performance Enhancers: A Retro- and Prospective Study Within the GEON.Drug Test Anal | Other paper | 2025 |
| GW501516 facilitated tumor immune escape by inhibiting phagocytosis.Eur J Pharmacol | Other paper | 2025 |
| Novel Solid Forms of Cardarine/GW501516 and Their Characterization by X-Ray Diffraction, Thermal, Computational, FTIR, and UV Analysis.Pharmaceutics | Other paper | 2025 |
| Peroxisome Proliferator-Activated Receptor δ Suppresses the Cytotoxicity of CD8+ T Cells by Inhibiting RelA DNA-Binding Activity.Cancer Res Commun | Other paper | 2024 |
| PPARβ/δ attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells.Biomed Pharmacother | Other paper | 2024 |
| The disordering effect of SARMs on a biomembrane model.Phys Chem Chem Phys | Other paper | 2024 |
| Activation of PPARδ in bone marrow endothelial progenitor cells improves their hematopoiesis-supporting ability after myelosuppressive injury.Cancer Lett | Other paper | 2024 |
| Five Novel Polymorphs of Cardarine/GW501516 and Their Characterization by X-ray Diffraction, Computational Methods, Thermal Analysis and a Pharmaceutical Perspective.Pharmaceutics | Other paper | 2024 |
| GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells.Cells | Other paper | 2024 |
| A screening method for the quantitative determination of selective androgen receptor modulators (SARMs) in capsules by high resolution 19F- and 1H-NMR spectroscopy.Anal Methods | Other paper | 2024 |
| PPARβ/δ-ANGPTL4 axis mediates the promotion of mono-2-ethylhexyl phthalic acid on MYCN-amplified neuroblastoma development.Sci Total Environ | Other paper | 2024 |
| Hydrogen sulfide ameliorates senescence in vascular endothelial cells through ameliorating inflammation and activating PPARδ/SGLT2/STAT3 signaling pathway.Acta Biochim Biophys Sin (Shanghai) | Other paper | 2023 |
| Peroxisome proliferator-activated receptor δ improves the features of atherosclerotic plaque vulnerability by regulating smooth muscle cell phenotypic switching.Br J Pharmacol | Other paper | 2023 |
| PPARβ/δ Agonism with GW501516 Increases Myotube PGC-1α Content and Reduces BCAA Media Content Independent of Changes in BCAA Catabolic Enzyme Expression.PPAR Res | Other paper | 2023 |
| PPARδ Agonist GW501516 Suppresses the TGF-β-Induced Profibrotic Response of Human Bronchial Fibroblasts from Asthmatic Patients.Int J Mol Sci | Other paper | 2023 |
| Integrative omics-analysis of lipid metabolism regulation by peroxisome proliferator-activated receptor a and b agonists in male Atlantic cod.Front Physiol | Other paper | 2023 |
| Small molecule-mediated rapid maturation of human induced pluripotent stem cell-derived cardiomyocytes.Stem Cell Res Ther | Other paper | 2022 |
| Cannabidiolic acid activates the expression of the PPARβ/δ target genes in MDA-MB-231 cells.Arch Biochem Biophys | Other paper | 2022 |
| Factors affecting the induction of uncoupling protein 1 in C2C12 myogenic cells.Cytokine | Other paper | 2022 |
| PPARδ Inhibits Hyperglycemia-Triggered Senescence of Retinal Pigment Epithelial Cells by Upregulating SIRT1.Antioxidants (Basel) | Other paper | 2022 |
| PPARδ Activation Mitigates 6-OHDA-Induced Neuronal Damage by Regulating Intracellular Iron Levels.Antioxidants (Basel) | Other paper | 2022 |
| Development and validation of SARMs and metabolic modulators screening in hair using UHPLC-MS/MS: Application to a doping case and first identification of S23 in authentic human hair.J Chromatogr B Analyt Technol Biomed Life Sci | Other paper | 2021 |
| Peroxisome Proliferator-Activated Receptor Delta Agonist (PPAR- δ) and Selective Androgen Receptor Modulator (SARM) Abuse: Clinical, Analytical and Biological Data in a Case Involving a Poisonous Combination of GW1516 (Cardarine) and MK2866 (Ostarine).Toxics | Other paper | 2021 |
| Catalase Mediates the Inhibitory Actions of PPARδ against Angiotensin II-Triggered Hypertrophy in H9c2 Cardiomyocytes.Antioxidants (Basel) | Other paper | 2021 |
| Development and validation of liquid chromatography-tandem mass spectrometry method for screening six selective androgen receptor modulators in dietary supplements.Food Addit Contam Part A Chem Anal Control Expo Risk Assess | Other paper | 2021 |
| Dexmedetomidine protects cardiac microvascular endothelial cells from the damage of ogd/r through regulation of the pparδ-mediated autophagy.Microcirculation | Other paper | 2021 |
| Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure.Mol Cell Biochem | Other paper | 2020 |
| Testing for GW501516 (cardarine) in human hair using LC/MS-MS and confirmation by LC/HRMS.Drug Test Anal | Other paper | 2020 |
| The Role of PPARδ Agosnist GW501516 in Rats with Gestational Diabetes Mellitus.Diabetes Metab Syndr Obes | Other paper | 2020 |
| Discovery and SAR of Natural-Product-Inspired RXR Agonists with Heterodimer Selectivity to PPARδ-RXR.ACS Chem Biol | Other paper | 2020 |
| PPARβ/δ Agonism Upregulates Forkhead Box A2 to Reduce Inflammation in C2C12 Myoblasts and in Skeletal Muscle.Int J Mol Sci | Other paper | 2020 |
| PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression.Mol Cancer Res | Other paper | 2020 |
| Cannabidiolic acid dampens the expression of cyclooxygenase-2 in MDA-MB-231 breast cancer cells: Possible implication of the peroxisome proliferator-activated receptor β/δ abrogation.J Toxicol Sci | Other paper | 2020 |
| Activation of peroxisome proliferator-activated receptor delta suppresses BACE1 expression by up-regulating SOCS1 in a JAK2/STAT1-dependent manner.J Neurochem | Other paper | 2019 |
| Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells.Eur J Pharmacol | Other paper | 2019 |
| PPARβ/δ Agonist GW501516 Inhibits Tumorigenesis and Promotes Apoptosis of the Undifferentiated Nasopharyngeal Carcinoma C666-1 Cells by Regulating miR-206.Oncol Res | Other paper | 2019 |
| PPARδ agonist prevents endothelial dysfunction via induction of dihydrofolate reductase gene and activation of tetrahydrobiopterin salvage pathway.Br J Pharmacol | Other paper | 2019 |
| Perilipin5 protects against lipotoxicity and alleviates endoplasmic reticulum stress in pancreatic β-cells.Nutr Metab (Lond) | Other paper | 2019 |
| Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes.Clin Investig Arterioscler | Other paper | 2019 |
| Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion.Cancer Res | Other paper | 2019 |
| Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy.Cancer Res | Other paper | 2019 |
| PPARδ agonist enhances colitis-associated colorectal cancer.Eur J Pharmacol | Other paper | 2019 |
| Ligand-activated interaction of PPARδ with c-Myc governs the tumorigenicity of breast cancer.Int J Cancer | Other paper | 2018 |
| The Effect of Hypoxia and Metformin on Fatty Acid Uptake, Storage, and Oxidation in L6 Differentiated Myotubes.Front Endocrinol (Lausanne) | Other paper | 2018 |
| PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis.Front Pharmacol | Other paper | 2018 |
| Ligand-Dependent Interaction of PPARδ With T-Cell Protein Tyrosine Phosphatase 45 Enhances Insulin Signaling.Diabetes | Other paper | 2018 |
| Detection of prohibited substances in equine hair by ultra-high performance liquid chromatography-triple quadrupole mass spectrometry - application to doping control samples.Drug Test Anal | Other paper | 2018 |
| Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516.Bioorg Med Chem Lett | Other paper | 2018 |
| Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosing.Bioorg Med Chem Lett | Other paper | 2017 |
| ADAMTS1-mediated targeting of TSP-1 by PPARδ suppresses migration and invasion of breast cancer cells.Oncotarget | Other paper | 2017 |
| Role of prostacyclin signaling in endothelial production of soluble amyloid precursor protein-α in cerebral microvessels.J Cereb Blood Flow Metab | Other paper | 2017 |
| Therapeutic potential of GW501516 and the role of Peroxisome proliferator-activated receptor β/δ and B-cell lymphoma 6 in inflammatory signaling in human pancreatic cancer cells.Biochem Biophys Rep | Other paper | 2016 |
| Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.Tumour Biol | Other paper | 2016 |